The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding .
Notice of Funding Opportunities
Title
Sort ascending
Announcement Number
Activity Code
Clinical Trials Status
Expiration Date
Program Official
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
PAR-21-330 (U01 Clinical Trial Not Allowed)
U01
Clinical Trial Not Allowed
10/12/2024
Claire Zhu, Ph.D.
Understanding Chronic Conditions Understudied Among Women
RFA-OD-23-013 (R21 Clinical Trial Optional)
R21
Clinical Trial Optional
06/21/2024
Goli Samimi, Ph.D., M.P.H.
Understanding Chronic Conditions Understudied Among Women
RFA-OD-23-014 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
06/21/2024
Goli Samimi, Ph.D., M.P.H.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research
RFA-CA-24-014 (P50 Clinical Trial Optional)
P50
Clinical Trial Optional
10/02/2024
Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research
RFA-CA-24-012 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
10/02/2024
Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research
RFA-CA-24-013 (U01 Clinical Trial Optional)
U01
Clinical Trial Optional
10/02/2024
Guillermo Marquez, Ph.D.
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities
PAR-22-064 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
01/08/2025
Pancreatic Cancer Detection Consortium: Research Units
PAR-21-334 (U01 Clinical Trial Optional)
U01
Clinical Trial Optional
06/12/2024
Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)
NOT-OD-22-202
Clinical Trial Not Allowed
04/16/2025
Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
NOT-NS-20-107
Clinical Trial Not Allowed
05/16/2024